Mirae Asset Global ETFs Holdings’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Buy
32,469
+782
+2% +$3.76K ﹤0.01% 2539
2025
Q4
$152K Buy
31,687
+1,963
+7% +$9.49K ﹤0.01% 2475
2025
Q3
$150K Sell
29,724
-5,374
-15% -$23.7K ﹤0.01% 2466
2025
Q2
$141K Buy
35,098
+345
+1% +$1.12K ﹤0.01% 2443
2025
Q1
$94.9K Buy
34,753
+1,482
+4% +$5.32K ﹤0.01% 2660
2024
Q4
$141K Buy
33,271
+2,232
+7% +$8.5K ﹤0.01% 2556
2024
Q3
$91.3K Buy
31,039
+126
+0.4% +$401 ﹤0.01% 2751
2024
Q2
$108K Buy
+30,913
New +$103K ﹤0.01% 2533

Other funds holding SRTA

Mirae Asset Global ETFs Holdings's SRTA Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Strata Critical Medical Inc (SRTA) stake by 2.5% in Q1 2026, buying an estimated $3.76K and bringing the position to 32,469 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #2539.

Mirae Asset Global ETFs Holdings first reported a position in SRTA in Q2 2024 and has held it in 8 quarters since. The position peaked at $152K in Q4 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 32,469 shares of Strata Critical Medical Inc worth $136K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 782 Strata Critical Medical Inc shares in Q1 2026, an estimated $3.76K.
  • Strata Critical Medical Inc made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2539 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Strata Critical Medical Inc in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Strata Critical Medical Inc position peaked at $152K in Q4 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.